Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms.

[1]  F. Asselbergs,et al.  Evaluation of Disease Progression in Arrhythmogenic Cardiomyopathy: The Change of Echocardiographic Deformation Characteristics Over Time. , 2020, JACC. Cardiovascular imaging.

[2]  S. Heymans,et al.  Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients Asymptomatic Dilated Cardiomyopathy. , 2020, JACC. Cardiovascular imaging.

[3]  Y. Pinto,et al.  Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. , 2019, European heart journal cardiovascular Imaging.

[4]  R. Hauer,et al.  The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update , 2019, Netherlands Heart Journal.

[5]  Karim Taha,et al.  The Prognostic Value of Right Ventricular Deformation Imaging in Early Arrhythmogenic Right Ventricular Cardiomyopathy. , 2019, JACC. Cardiovascular imaging.

[6]  J. Healey,et al.  Phospholamban cardiomyopathy: a Canadian perspective on a unique population , 2019, Netherlands Heart Journal.

[7]  R. D. de Boer,et al.  Prevalence and cardiac phenotype of patients with a phospholamban mutation , 2018, Netherlands Heart Journal.

[8]  B. Gerber,et al.  Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging , 2018, European heart journal cardiovascular Imaging.

[9]  Gilbert Habib,et al.  Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging. , 2017, European heart journal cardiovascular Imaging.

[10]  Tammo Delhaas,et al.  Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[11]  S. Heymans,et al.  Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.

[12]  M. Link,et al.  Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2015, Circulation.

[13]  Ronald A. Li,et al.  Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy , 2015, Nature Communications.

[14]  J. P. Tintelen,et al.  Mutación p.Arg14del en fosfolambán en una familia española con miocardiopatía arritmogénica: evidencia de una mutación europea fundadora , 2015 .

[15]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[16]  H. Young,et al.  Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy. , 2015, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[17]  R. Hauer,et al.  Outcome in Phospholamban R14del Carriers: Results of a Large Multicentre Cohort Study , 2014, Circulation. Cardiovascular genetics.

[18]  A. Wilde,et al.  Ventricular dysfunction in a family with long QT syndrome type 3. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  J. G. Post,et al.  Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy , 2013, Netherlands Heart Journal.

[20]  R. Hauer,et al.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. , 2015, European heart journal.

[21]  R. Hauer,et al.  Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.

[22]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[23]  R. Hetzer,et al.  Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. , 2009, Heart Rhythm.

[24]  N. Prakken,et al.  Echocardiographic tissue deformation imaging of right ventricular systolic function in endurance athletes. , 2008, European heart journal.

[25]  Kristina Hermann Haugaa,et al.  Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome , 2008, European heart journal.

[26]  P. Doevendans,et al.  Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking , 2007 .

[27]  B. Soliven,et al.  Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[28]  G. Dorn,et al.  A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Seward,et al.  Apex-to-base dispersion in regional timing of left ventricular shortening and lengthening. , 2006, Journal of the American College of Cardiology.

[30]  E. Kranias,et al.  Calcium: Phospholamban: a crucial regulator of cardiac contractility , 2003, Nature Reviews Molecular Cell Biology.

[31]  J. Voigt,et al.  Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  R. N. Planken,et al.  Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging , 2019, European heart journal cardiovascular Imaging.

[33]  G. Pedrizzetti,et al.  Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. , 2015, European heart journal cardiovascular Imaging.